The use of JAK vs TNF inhibitors shows no significant increase in the incidence of major adverse cardiovascular events in ...

AbbVie had a strong Q1 performance in its oncology, neuroscience, and immunology franchises. Read why I continue to rate ABBV ...

AbbVie Inc.'s Q1 earnings highlight an 8.4% revenue boost, driven by Skyrizi & Rinvoq. Click for ABBV's market expansion, ...

TNF Pharmaceuticals, Inc. ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, and Renova Health ...

Review highlights how vitamin D, particularly its active form calcitriol, modulates immune responses, inflammation, and tumor ...

TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to ...

BRIDGEWATER, NJ / ACCESS Newswire / April 15, 2025 / Tharimmune, Inc. (NASDAQ:THAR), a clinical-stage biotechnology company advancing novel solutions in immunology and oncology, today announced the ap ...

The use of TNF inhibitors was not linked to worse survival outcomes among patients with rheumatoid arthritis during the 3 years after being diagnosed with lung, colorectal, or prostate cancer.

If you've been feeling bloated, sluggish, or just not quite like yourself, there's a good chance inflammation is at play. Chronic inflammation has been linked to fatigue, joint pain, gut issues, and ...